Browse > Article
http://dx.doi.org/10.3350/kjhep.2009.15.1.59

The value of serum retinol-binding protein 4 levels for determining disease severity in patients with chronic liver disease  

Kwon, Jung-Hyun (Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
Park, Seong-Tae (Catholic Research Institutes of Medical Science)
Kim, Gi-Dae (Catholic Research Institutes of Medical Science)
You, Chan-Ran (Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
Kim, Jin-Dong (Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
Woo, Hyun-Young (Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
Jang, Jeong-Won (Catholic Research Institutes of Medical Science)
Kim, Chang-Wook (Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
Bae, Si-Hyun (Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
Choi, Jong-Young (Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
Yoon, Seung-Kew (Department of Internal Medicine, College of Medicine, The Catholic University of Korea)
Publication Information
Clinical and Molecular Hepatology / v.15, no.1, 2009 , pp. 59-69 More about this Journal
Abstract
Backgrounds/Aims: Serum retinol-binding protein 4 (RBP4) is known to be a specific transport protein for retinol, and has recently been reported to be associated with insulin resistance. Hyaluronic acid (HA) is a well-known marker of liver fibrosis. In this study, the degree to which serum RBP4 levels can be used to predict disease severity in patients with chronic liver disease (CLD) was evaluated. Methods: Serum levels of RBP4 and HA were measured in 573 CLD patients [235 with chronic hepatitis (CH), 230 with liver cirrhosis Child-Pugh grade (Child) A, and 108 with liver cirrhosis with Child B and C] and 40 normal controls. Results: The mean age of the whole cohort was 53.1 years and the causes of CLD were hepatitis B virus (61.9%), hepatitis C virus (9.8%), alcohol (9.0%), and nonalcoholic steatohepatitis (3.8%). Serum levels of RBP4 significantly reduced and HA increased with disease condition, from none (normal controls) to advanced cirrhosis (normal control: RBP4 4.3${\pm}$0.1 mg/dL, HA 25.3${\pm}$28.1 ng/mL;CH: RBP4 3.6${\pm}$0.1 mg/dL, HA 75.5${\pm}$7.8 ng/mL;cirrhosis with Child A: RBP4 2.6${\pm}$0.1 mg/dL, HA 184.4${\pm}$14.5 ng/mL;and cirrhosis with Child B and C: RBP4 1.6${\pm}$0.1 mg/dL, HA 656.5${\pm}$86.7 ng/mL;P<0.001, respectively). Serum RBP4 level was a distinguishing factor at the early stage of CLD between CH and Child A cirrhosis (post-hoc test;P<0.001) and was correlated with histological fibrosis score (n=80, P<0.05) and several biochemical factors. Antiviral therapy (n=45, median interval 1,205 days) resulted in an improvement in serum RBP4 levels (P=0.001). Conclusions: The results of our study suggest that RBP4 is a serologic marker for disease severity in patients with CLD. It could also be useful as an early marker of CLD and of the relative success of antiviral therapy.
Keywords
Chronic liver disease; Serologic marker; Retinol-Binding Proteins; Plasma; Hyaluronic Acid;
Citations & Related Records
Times Cited By KSCI : 2  (Citation Analysis)
Times Cited By SCOPUS : 4
연도 인용수 순위
1 Kanai M, Raz A, Goodman DS. Retinol-binding protein: the transport protein for vitamin A in human plasma. J Clin Invest 1968;47:2025-2044   DOI   PUBMED
2 Seo JA, Kim NH, Park SY, Kim HY, Ryu OH, Lee KW, et al. Serum retinol-binding protein 4 levels are elevated in non-alcoholic fatty liver disease. Clin Endocrinol (Oxf) 2008;68:555-560   DOI   ScienceOn
3 Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 2004;99:1160-1174   DOI   ScienceOn
4 Iloeje UH, Yang HI, Su J, Jen CL, You SL, Chen CJ. Predicting cirrhosis risk based on the level of circulating hepatitis B viral load. Gastroenterology 2006;130:678-686   DOI   ScienceOn
5 Lee JI, Park HJ, Lee JW, Kim YS, Jeong S, Lee DH, et al. Pretreatment alanine transaminase level may not be the most important predictor of HBeAg loss in the older patient. Liver Int 2009;29:231-236   DOI   PUBMED   ScienceOn
6 Yagmur E, Weiskirchen R, Gressner AM, Trautwein C, Tacke F. Insulin resistance in liver cirrhosis is not associated with circulating retinol-binding protein 4. Diabetes Care 2007;30:1168-1172   DOI   ScienceOn
7 Bahr MJ, Boeker KH, Manns MP, Tietge UJ. Decreased hepatic RBP4 secretion is correlated with reduced hepatic glucose production but not associated with insulin resistance in patients with liver cirrhosis. Clin Endocrinol (Oxf) 2009;70:60-65   DOI   ScienceOn
8 Newcomer ME, Ong DE. Plasma retinol binding protein: structure and function of the prototypic lipocalin. Biochim Biophys Acta 2000;1482:57-64   DOI   PUBMED   ScienceOn
9 Harrison EH, Smith JE, Goodman DS. Effects of vitamin A deficiency on the levels and distribution of retinolbinding protein and marker enzymes in homogenates and Golgi-rich fractions of rat liver. Biochim Biophys Acta 1980;628:489-497   PUBMED   ScienceOn
10 Ballmer PE, Walshe D, McNurlan MA, Watson H, Brunt PW, Garlick PJ. Albumin synthesis rates in cirrhosis: correlation with Child-Turcotte classification. Hepatology 1993;18:292-297   DOI   ScienceOn
11 Engstrom-Laurent A, Loof L, Nyberg A, Schroder T. Increased serum levels of hyaluronate in liver disease. Hepatology 1985;5:638-642   DOI   PUBMED
12 Lee D, Jeong SH, Lee M, Cho YA, Kim JW, Park Y, et al. The prevalence of peripheral iron overload and the presence of HFE gene (H63D) mutation among the Korean patients with nonalcoholic fatty liver disease. Korean J Hepatol 2007;13:174-184   PUBMED   ScienceOn
13 Sud A, Hui JM, Farrell GC, Bandara P, Kench JG, Fung C, et al. Improved prediction of fibrosis in chronic hepatitis C using measures of insulin resistance in a probability index. Hepatology 2004;39:1239-1247   DOI   ScienceOn
14 Blomhoff R, Green MH, Berg T, Norum KR. Transport and storage of vitamin A. Science 1990;250:399-404   DOI   PUBMED
15 Wu H, Jia W, Bao Y, Lu J, Zhu J, Wang R, et al. Serum retinol binding protein 4 and nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus. Diabetes Res Clin Pract 2008;79:185-190   DOI   ScienceOn
16 Muzzi A, Leandro G, Rubbia-Brandt L, James R, Keiser O, Malinverni R, et al. Insulin resistance is associated with liver fibrosis in non-diabetic chronic hepatitis C patients. J Hepatol 2005;42:41-46   DOI   ScienceOn
17 Bugianesi E, McCullough AJ, Marchesini G. Insulin resistance: a metabolic pathway to chronic liver disease. Hepatology 2005;42:987-1000   DOI   ScienceOn
18 Yang Q, Graham TE, Mody N, Preitner F, Peroni OD, Zabolotny JM, et al. Serum retinol binding protein 4 contributes to insulin resistance in obesity and type 2 diabetes. Nature 2005;436:356-362   DOI   ScienceOn
19 Fontana RJ, Goodman ZD, Dienstag JL, Bonkovsky HL, Naishadham D, Sterling RK, et al. Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C. Hepatology 2008;47:789-798   DOI   ScienceOn
20 Petta S, Camma C, Di Marco V, Alessi N, Barbaria F, Cabibi D, et al. Retinol-binding protein 4: a new marker of virus-induced steatosis in patients infected with hepatitis c virus genotype 1. Hepatology 2008;48:28-37   DOI   ScienceOn
21 Lok AS, McMahon BJ. Chronic hepatitis B. Hepatology 2007;45:507-539   DOI   ScienceOn
22 Graham TE, Yang Q, Bluher M, Hammarstedt A, Ciaraldi TP, Henry RR, et al. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med 2006;354:2552-2563   DOI   ScienceOn
23 Manning DS, Afdhal NH. Diagnosis and quantitation of fibrosis. Gastroenterology 2008;134:1670-1681   DOI   ScienceOn
24 Nelson JE, Bhattacharya R, Lindor KD, Chalasani N, Raaka S, Heathcote EJ, et al. HFE C282Y mutations are associated with advanced hepatic fibrosis in Caucasians with nonalcoholic steatohepatitis. Hepatology 2007;46:723-729   DOI   ScienceOn
25 Ananian P, Hardwigsen J, Bernard D, Le Treut YP. Serum acute-phase protein level as indicator for liver failure after liver resection. Hepatogastroenterology 2005;52:857-861   PUBMED   ScienceOn
26 Kim MY, Baik SK, Jang YO, Suk KT, Kim JW, Kim HS, et al. Serum hyaluronic acid level: correlation with quantitative measurement of hepatic fibrosis in a cirrhotic rat model. Korean J Hepatol 2008;14:159-167   DOI   ScienceOn
27 Wong VS, Hughes V, Trull A, Wight DG, Petrik J, Alexander GJ. Serum hyaluronic acid is a useful marker of liver fibrosis in chronic hepatitis C virus infection. J Viral Hepat 1998;5:187-192   DOI   ScienceOn
28 Feranchak AP, Gralla J, King R, Ramirez RO, Corkill M, Narkewicz MR, et al. Comparison of indices of vitamin A status in children with chronic liver disease. Hepatology 2005;42:782-792   DOI   ScienceOn
29 Imbert-Bismut F, Ratziu V, Pieroni L, Charlotte F, Benhamou Y, Poynard T. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study. Lancet 2001;357:1069-1075   DOI   PUBMED   ScienceOn
30 Kim CW, Yoon SK, Jo BS, Shin JY, Jang JW, Choi JY, et al. Prediction of hepatic fibrosis using serum hyaluronic acid in patients with chronic liver disease. Korean J Gastroenterol 2003;42:510-518   PUBMED
31 Isozaki M, Masubuchi Y, Horie T. Retinol binding protein in plasma to evaluate the hepatotoxicity of rats treated with CCl4. Res Commun Mol Pathol Pharmacol 2001;110: 303-310   PUBMED   ScienceOn
32 Poynard T, Imbert-Bismut F, Ratziu V, Chevret S, Jardel C, Moussalli J, et al. Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J Viral Hepat 2002;9:128-133   DOI   ScienceOn